How Ozempic and Other GLP-1 Drugs Are Eating Away at Body Positivity
How GLP-1 drugs like Mounjaro and Ozempic are redefining the debate about size, weight loss and privilege
Apr 30
Telehealth patients get access to more weight-loss drugs
Click in for more news from The Hill {beacon} Health Care The Big Story Novo Nordisk partners with telehealth firms to sell Wegovy Novo Nordisk is working with telehealth companies to sell a cheaper version of its injectable weight-loss drug Wegovy, launching the partnership after these companies became unable to sell compounded, unapproved versions … Read more
Novo Nordisk Forms GLP-1 Partnership with Hims & Hers
Hims & Hers is now offering discounted access to Wegovy, a GLP-1 manufactured by Novo Nordisk, on its platform. The post Novo Nordisk Forms GLP-1 Partnership with Hims & Hers appeared first on MedCity News.
Little Evidence That GLP-1 Agonists Affect Fertility in Men
(MedPage Today) — LAS VEGAS — A history of treatment with a GLP-1 receptor agonist had limited impact on sperm abnormalities in men with obesity, a retrospective cohort study suggested. Men who had at least one prescription for semaglutide…
Ozempic Blindness Lawsuit; CGM Integrates With Epic; Microdosing GLP-1 Meds
(MedPage Today) — A Maryland man with diabetes is suing Novo Nordisk, alleging that semaglutide (Ozempic, Wegovy) made him blind due to nonarteritic anterior ischemic optic neuropathy. (NBC News) In a large study of diabetes, heart failure, or…
Ozempic May Cause Cosmetic Side Effects Like Sagging Skin, Wrinkly Feet
Recent anecdotal reports have highlighted strange side effects of GLP-1 medications used for weight loss like “Ozempic mouth” and “Ozempic feet.” Elena Popova/Getty Images “Ozempic feet” and “Ozempic mouth” are the latest reported cosmetic side effects from GLP-1 medications used for weight loss. Experts say wrinkles and sagging skin can result from rapid weight loss … Read more
Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers – Reuters
Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers Reuters Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18% CNBC Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership Yahoo Finance LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients GlobeNewswire Novo Nordisk strikes telehealth deals … Read more
GIP receptor shows surprising dual action: Both activation and blockade support weight loss
Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and diabetes. Surprisingly, active substances are currently being developed that not only activate the GIP receptor (agonists) but also block it (antagonists). They also have a positive effect on body weight.
From diet to drugs: what really works for long-term weight loss
voronaman/Shutterstock More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health Organization. This staggering number highlights a growing global health crisis. Obesity isn’t just about weight – it’s a powerful risk factor for a range of serious diseases, including type 2 diabetes, kidney disease, heart attacks, and … Read more
This is the end of GLP-1 compounding as we know it
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, we’ve got a bunch of news this morning about GLP-1 drugs, compounding, and biotechs’ interactions with the FDA. Let’s get into it. Read the rest…